Lezack Adam sold Beta Bionics, Inc. ($BBNX) shares on the open market four times in the last year, for a total of about $79,323. His most recent sale was on December 1, 2025. These transactions rank 9,890th among 11,678 insiders in our database, well below the average sale amount of $8.6 million across 6.4 transactions per insider. Adam had no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 13, 2026 | Beta Bionics, Inc. | $BBNX | Lezack Adam | Not found | A | Common Stock | 3997 | $0.00 | 12,432.0000 | 44,024,631 | 47.39% | 0.01% |
| Dec. 1, 2025 | Beta Bionics, Inc. | $BBNX | Lezack Adam | Not found | S | Common Stock | 500 | $29.91 | 8,435.0000 | 44,024,631 | 5.60% | 0.00% |
| Dec. 1, 2025 | Beta Bionics, Inc. | $BBNX | Lezack Adam | Not found | S | Common Stock | 906 | $29.35 | 8,935.0000 | 44,024,631 | 9.21% | 0.00% |
| Oct. 31, 2025 | Beta Bionics, Inc. | $BBNX | Lezack Adam | Not found | S | Common Stock | 38 | $27.70 | 9,841.0000 | 44,024,631 | 0.38% | 0.00% |
| Oct. 31, 2025 | Beta Bionics, Inc. | $BBNX | Lezack Adam | Not found | S | Common Stock | 1368 | $26.85 | 9,879.0000 | 44,024,631 | 12.16% | 0.00% |
| March 15, 2025 | Beta Bionics, Inc. | $BBNX | Lezack Adam | Not found | A | Common Stock | 11247 | $0.00 | 11,247.0000 | 43,348,840 | 9999.99% | 0.03% |
| Jan. 31, 2025 | Beta Bionics, Inc. | $BBNX | Lezack Adam | Not found | A | Director Stock Option (right to buy) | 9137 | $0.00 | 9,137.0000 | 0 | 9999.99% | 0.00% |